A paradigm shift towards the IL-23/IL-17 axis as the central mechanism of the pro-inflammatory cycle of psoriasis has questioned the relevance of Th1 cells and IFN-y as the main drivers of the disease. The gene discussed is IL17A; the disease is psoriasis.